SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-009895
Filing Date
2023-03-30
Accepted
2023-03-30 16:09:17
Documents
16
Period of Report
2023-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20230330.htm   iXBRL 8-K 27512
2 EX-99.1 exhibit991_33023pressrelea.htm EX-99.1 28951
6 GRAPHIC advm_bsa.jpg GRAPHIC 87370
7 GRAPHIC advm_isxfy22a.jpg GRAPHIC 61117
8 GRAPHIC logo.jpg GRAPHIC 9327
  Complete submission text file 0001628280-23-009895.txt   408365

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20230330.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20230330_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20230330_pre.xml EX-101.PRE 12506
10 EXTRACTED XBRL INSTANCE DOCUMENT advm-20230330_htm.xml XML 4086
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 23780762
SIC: 2836 Biological Products, (No Diagnostic Substances)